Arterium presents motion sickness medication

Arterium Corporation has presented a new product in Uzbekistan—Dramina motion sickness pills. The medicinal product's active ingredient is dimenhydrinate. Its purpose is to relieve motion sickness symptoms like dizziness, nausea, and vomiting in children and adults. Dramina quickly relieves symptoms of motion sickness, from which statistically every 6^th adult and every 4^th child suffers. Inducing histamine receptor blockade, the product exhibits anti-nauseant, anti-emetic, sedative, and anti-allergic action, as well as mitigates dizziness. Arterium Corporation exclusively markets Dramina in the Uzbek market as part of its partnership with Croatia's JDL.